Clinical Drug Experience Knowledgebase

Afibrinogenemia (Phase 3)

Agammaglobulinemia (Phase 3)

alpha 1-Antitrypsin Deficiency (Phase 2)

Alzheimer Disease (Phase 2)

Aneurysm (Phase 4)

Antithrombin III Deficiency (Phase 4)

Aortic Aneurysm (Phase 4)

Aortic Aneurysm, Thoracic (Phase 4)

Dermatomyositis (Phase 3)

Disease Progression (Phase 3)

Encephalitis (Phase 3)

Hemophilia A (Phase 3)

Hemorrhage (Phase 4)

Immunologic Deficiency Syndromes (Phase 4)

Infections (Phase 4)

Inflammation (Phase 3)

Leukemia (Phase 3)

Leukemia, Lymphocytic, Chronic, B-Cell (Phase 3)

Leukemia, Lymphoid (Phase 3)

Liver Diseases (Phase 4)

Peripheral Nervous System Diseases (Phase 3)

Polyradiculoneuropathy (Phase 3)

Polyradiculoneuropathy, Chronic Inflammatory Demyelinating (Phase 3)

Pre-Eclampsia (Phase 4)

Purpura (Phase 3)

Purpura, Thrombocytopenic (Phase 3)

Purpura, Thrombocytopenic, Idiopathic (Phase 4)

Purpura, Thrombotic Thrombocytopenic (Phase 3)

Shock (Phase 4)

Shock, Septic (Phase 4)

Streptococcal Infections (Phase 4)

Syndrome (Phase 4)

Thrombocytopenia (Phase 4)

von Willebrand Diseases (Phase 3)